Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
matteo.garibaldi@uniroma1.it
Matteo Garibaldi
Ricercatore
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
matteo.garibaldi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Eculizumab improves fatigue in refractory generalized myasthenia gravis
QUALITY OF LIFE RESEARCH
2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
MUSCLE & NERVE
2019
Thymomatous myasthenia gravis. novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity
JOURNAL OF NEUROLOGY
2019
Italian recommendations for diagnosis and management of congenital myasthenic syndromes
NEUROLOGICAL SCIENCES
2019
Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case–control study
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2019
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients
JOURNAL OF NEUROLOGY
2019
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY
2019
A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy
DISEASE MODELS & MECHANISMS
2019
Dusty core disease (DuCD): expanding morphological spectrum of RYR1 recessive myopathies
ACTA NEUROPATHOLOGICA COMMUNICATIONS
2019
Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study
JOURNAL OF THE NEUROLOGICAL SCIENCES
2019
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)
QUALITY OF LIFE RESEARCH
2019
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
JOURNAL OF THE NEUROLOGICAL SCIENCES
2019
A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre
JOURNAL OF NEUROLOGY
2018
Core-rod myopathy due to a novel mutation in BTB/POZ domain of KBTBD13 manifesting as late onset LGMD
ACTA NEUROPATHOLOGICA COMMUNICATIONS
2018
Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation
CLINICAL NEUROPHYSIOLOGY
2018
Lipid Myopathies
JOURNAL OF CLINICAL MEDICINE
2018
Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome
AMERICAN JOURNAL OF MEDICAL GENETICS. PART A
2018
Long term follow-up of cerebrovascular abnormalities in late onset pompe disease (LOPD)
JOURNAL OF NEUROLOGY
2017
Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity
THE JOURNAL OF CLINICAL INVESTIGATION
2017
Recessive MYPN mutations cause cap myopathy with occasional nemaline rods
ANNALS OF NEUROLOGY
2017
« prima
< precedente
1
2
3
4
5
seguente ›
ultima »
Progetti di Ricerca
Muscle pathology in Immune Mediated Necrotizing Myopathy (IMNM): implications for diagnostic accuracy and treatment strategies
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma